Background-Pathological tau protein concentrations in CSF are found in both
Alzheimer's disease (AD) and frontotemporal dementia (FTD), but studies on
brain tissue have suggested that the tall pathology in XD differs from tha
t in FTD and that the difference may be related to the degree of phosphoryl
ation,;Is CSF tau protein is increased after stroke, tau may also be implic
ated in the pathophysiology of vascular dementia, of which subcortical arte
riosclerotic encephalopathy (SAE) is a putative subtype.
Objectives-To investigate the nature of tau protein in CSF and the involvem
ent of total CSF tau and phosphorylated CSF tau (phosphotau) in various typ
es of dementia.
Methods-Using ELISAs for total tau and tau phosphorylated at Thr181 (phosph
otau), the CSF concentrations of total tau and phosphotau were determined i
n patients with probable and possible AD (n= 41 and 19, respectively), FTD
(n=18), SAE (n=17), and Parkinson's disease (PD; n=15) and in age matched c
ontrols (n=17). All the antibodies stained the lower molecular weight bands
, whereas only the antibodies that recognise phosphorylated tau stained the
higher molecular bands.
Results-Both CSF tau and CSF phosphotau were increased in probable, AD comp
ared (p <0.001), PD (p <0.001), and controls (p <0.001). CSF phosphotau was
increased in possible AD compared with FTB (p <0.001) and SAE (p <0.001).
CSF tau and CSF phosphotau were positively correlated in all the groups. Mo
lecular weight farms of tau ranging from 25 kDa to 80 kDa were found in the
CSF
Conclusion-Both phosphorylated and unphosphorylated tau isoforms mere prese
nt in the CSF, and tau protein appeared in both truncated and full length f
orms. The results suggest that the CSF concentrations of tau and phosphotau
are increased in about two thirds of patients with probable AD and in half
of those with possible AD but are normal in FTD, SAE, and PD compared with
normal aging. Values ill the normal range do not exclude AD.